BioCentury
ARTICLE | Clinical News

Actos pioglitazone HCL endocrine data

June 1, 2009 7:00 AM UTC

A meta-analysis of data from 33,040 Type II diabetes patients enrolled in the ADVANCE, UKPDS, PROactive, VADT and ACCORD trials showed that intensive glycemic control produced a 17% reduction in event...